Operating profit Celltrion 2017-2023
In 2023, the operating profit of biopharmaceutical company Celltrion amounted to around 651.5 billion South Korean won. This represents a slight increase compared to the previous year. Celltrion is one of the most successful pharmaceutical businesses in South Korea.